Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Biochemical and Biophysical Research Communications
|
June 7, 2025
TLE1 drives EGFR-TKI resistance in EGFR-mutant lung adenocarcinoma through epithelial to mesenchymal transition
Ma Carmela Dela Cruz, Xin Yao, Nasir Roberts, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 16, 2004
Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells
Pirjo Laakkonen, Maria E Akerman, Hector Biliran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 17, 2008
Anti-invasive and antimetastatic activities of ribosomal protein S6 kinase 4 in breast cancer cells
Archana Thakur, Yuan Sun, Aliccia Bollig, et al.
Plos One
|
September 23, 2016
The Anoikis Effector Bit1 Inhibits EMT through Attenuation of TLE1-Mediated Repression of E-Cadherin in Lung Cancer Cells
Xin Yao, Tri Pham, Brandi Temple, et al.
Plos One
|
July 9, 2014
The anoikis effector Bit1 displays tumor suppressive function in lung cancer cells
Xin Yao, Scott Jennings, Shubha Kale Ireland, et al.
Anticancer Research
|
March 27, 2026
BIT1 as an Effector of EGFR-TKI-induced Apoptosis <i>via</i> TLE1 Inhibition in Lung Adenocarcinoma Cells
Ma Carmela Dela Cruz, Xin Yao, Alajah Nealy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2007
c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells
Hector Biliran, Sanjeev Banerjee, Archana Thakur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2005
Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line
Hector Biliran, Yong Wang, Sanjeev Banerjee, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 26, 2008
Anoikis effector Bit1 negatively regulates Erk activity
Rania Kairouz-Wahbe, Hector Biliran, Xiuquan Luo, et al.
Biochemical and Biophysical Research Communications
|
November 25, 2017
Downregulation of Bit1 expression promotes growth, anoikis resistance, and transformation of immortalized human bronchial epithelial cells via Erk activation-dependent suppression of E-cadherin
Xin Yao, Selena Gray, Tri Pham, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Biochemical and Biophysical Research Communications
|
June 7, 2025
TLE1 drives EGFR-TKI resistance in EGFR-mutant lung adenocarcinoma through epithelial to mesenchymal transition
Ma Carmela Dela Cruz, Xin Yao, Nasir Roberts, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 16, 2004
Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells
Pirjo Laakkonen, Maria E Akerman, Hector Biliran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 17, 2008
Anti-invasive and antimetastatic activities of ribosomal protein S6 kinase 4 in breast cancer cells
Archana Thakur, Yuan Sun, Aliccia Bollig, et al.
Plos One
|
September 23, 2016
The Anoikis Effector Bit1 Inhibits EMT through Attenuation of TLE1-Mediated Repression of E-Cadherin in Lung Cancer Cells
Xin Yao, Tri Pham, Brandi Temple, et al.
Plos One
|
July 9, 2014
The anoikis effector Bit1 displays tumor suppressive function in lung cancer cells
Xin Yao, Scott Jennings, Shubha Kale Ireland, et al.
Anticancer Research
|
March 27, 2026
BIT1 as an Effector of EGFR-TKI-induced Apoptosis <i>via</i> TLE1 Inhibition in Lung Adenocarcinoma Cells
Ma Carmela Dela Cruz, Xin Yao, Alajah Nealy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2007
c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells
Hector Biliran, Sanjeev Banerjee, Archana Thakur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2005
Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line
Hector Biliran, Yong Wang, Sanjeev Banerjee, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 26, 2008
Anoikis effector Bit1 negatively regulates Erk activity
Rania Kairouz-Wahbe, Hector Biliran, Xiuquan Luo, et al.
Biochemical and Biophysical Research Communications
|
November 25, 2017
Downregulation of Bit1 expression promotes growth, anoikis resistance, and transformation of immortalized human bronchial epithelial cells via Erk activation-dependent suppression of E-cadherin
Xin Yao, Selena Gray, Tri Pham, et al.
Page
of 3